Evaluation of serological response to anti-SARS-CoV-2 mRNA vaccination in hematological patients
ConclusionsOur data confirm reduced serological response in hematological patients after anti-SARS-CoV-2 vaccination. However, we found a great diversity of SARS-CoV-2 antibody response according to types of pathologies and therapies.
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research
More News: Acute Leukemia | Allergy & Immunology | Cancer & Oncology | Chemistry | Chronic Leukemia | Chronic Myeloid Leukaemia | Hematology | Italy Health | Leukemia | Rituxan | SARS | Statistics | Stem Cell Therapy | Stem Cells | Study | Transplants | Vaccines